Galmed Pharmaceuticals (EOCN) EBIT (2013 - 2024)
Galmed Pharmaceuticals (EOCN) reported EBIT of $1.82 million for FY2025, down 17.2% from $2.2 million in FY2024.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) EBIT (2013 - 2024) Analysis & Trends
Dating back to FY2011, Galmed Pharmaceuticals' EBIT record includes 15 years.
- EBIT has declined for four consecutive years, with a five-year compound annual growth rate of -43.0% (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual EBIT since FY2011.
- According to Business Quant data, EBIT came in at $2.2 million in FY2024 (-70.6%), $7.49 million in FY2023 (-57.6%), $17.65 million in FY2022 (-46.3%) and $32.88 million in FY2021 (+8.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.65 Bn | 1,100.24 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 615.89 Bn | 534.41 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 505.03 Bn | 478.14 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 368.78 Bn | 323.16 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.66 Bn | 262.65 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 262.09 Bn | 235.78 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.57 Bn | 191.97 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.05 Bn | 165.25 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.60 Bn | 117.25 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Galmed Pharmaceuticals | 1.60 Mn | -39.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 653,000.00 |
| Jun 30, 2023 | 573,000.00 |
| Mar 31, 2023 | -588,000.00 |
| Jun 30, 2022 | 286,000.00 |
| Mar 31, 2022 | -250,000.00 |
| Jun 30, 2020 | -5.82 Mn |
| Mar 31, 2020 | 6.46 Mn |
| Dec 31, 2019 | -32.64 Mn |
| Sep 30, 2019 | 4.51 Mn |
| Jun 30, 2019 | -4.70 Mn |
| Mar 31, 2019 | 4.04 Mn |
| Dec 31, 2018 | -17.23 Mn |
| Sep 30, 2018 | 1.18 Mn |
| Jun 30, 2018 | -2.69 Mn |
| Mar 31, 2018 | 2.56 Mn |
| Dec 31, 2017 | -21.08 Mn |
| Sep 30, 2017 | 2.76 Mn |
| Jun 30, 2017 | -2.69 Mn |
| Mar 31, 2017 | 3.26 Mn |
| Dec 31, 2016 | 4.75 Mn |
API Access
Galmed Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();